A PET-CT scan is a single imaging test that combines PET (positron emission tomography) with CT (computed tomography) to support cancer diagnosis, staging, and treatment planning.
At HCG centers in India, this combined scan, often shortened to "PET scan," shows how actively cells are using energy, while CT shows the exact size, shape, and location of that activity.
A PET scan alone captures only the metabolic picture; combining it with CT is what lets a specialist match that activity to a specific organ or structure. On its own, a PET-CT scan cannot confirm cancer.
Unusual activity still needs to be read alongside other findings, and sometimes a biopsy, before a diagnosis is made.
HCG provides PET-CT scanning at selected centers in India. Explore the verified HCG PET-CT scan centers below to confirm local availability, PET-CT technology, scan protocols, and appointment requirements. Services may differ by hospital, so patients should confirm the prescribed scan with the preferred center before booking.
A PET-CT scan may be recommended at several points in cancer care. It is ordered by a treating specialist for a defined clinical reason, not as a routine test.
Common reasons include:
PET-CT supports these decisions. It does not replace them. A specialist reads the scan together with the clinical history, physical examination, laboratory results, and, where relevant, pathology findings.
A PET-CT scan can show:
An important qualification: increased tracer uptake does not always mean cancer. Infection, inflammation, and normal organ activity may also cause increased uptake, so PET-CT findings must be interpreted by a qualified specialist alongside the patient's history and other test results.
The reverse is also true. Some cancers are slow-growing or have low metabolic activity, and these may show little uptake even when disease is present.
The radiotracer and PET-CT protocol selected depend on the cancer type and clinical indication. HCG centers may offer different PET-CT technologies and scan protocols depending on local availability.
FDG stands for fluorodeoxyglucose, a form of glucose tagged with a radioactive marker. Because many cancer cells consume glucose at a higher rate than surrounding tissue, FDG tends to concentrate in metabolically active areas.
FDG PET-CT is the most widely used form of PET imaging in oncology and is applied across a range of cancer types for staging, response assessment, and recurrence evaluation. Its usefulness varies by tumor type.
PSMA stands for prostate-specific membrane antigen, a protein found in higher concentrations on many prostate cancer cells.
PSMA PET-CT is used in selected prostate cancer situations, such as assessing the extent of disease or investigating a rising PSA level after treatment. Whether it is appropriate depends on the clinical stage and the treating specialist's assessment.
These tracers bind to somatostatin receptors, which are present in higher numbers on many neuroendocrine tumor cells.
This form of imaging is used in selected neuroendocrine tumor cases to locate the primary tumor, assess spread, and help determine whether certain receptor-targeted treatments may be suitable.
Digital PET-CT uses newer detector technology that can improve image clarity and may allow imaging at a lower tracer dose in appropriate cases.
Availability differs by center. You can read more about this on our dedicated page covering Digital PET-CT technology.
The examination follows a predictable sequence:
The waiting period after the tracer is given is often referred to as the uptake phase. Patients are usually asked to stay still and avoid talking or moving unnecessarily during this time, because muscle activity can draw tracer into the muscles and affect image quality.
Have the following ready when you contact your preferred HCG center:
The center uses this to confirm the correct scan type and radiotracer, check technology availability, and plan the uptake-period timing before your visit.
Preparation instructions come from the center performing the scan and should be followed closely, since image quality depends on them.
Points typically covered include:
Preparation can vary depending on the radiotracer, scan protocol, and medical condition. Patients should follow the instructions provided by the PET-CT center.
Registration is completed, and a member of the team reviews the medical history, current medicines, and the referring prescription. Where required, blood glucose is checked. The radiotracer is then administered, usually through a vein. The patient rests quietly during the uptake period.
The patient lies on a scanning table that moves slowly through the ring-shaped scanner. Remaining still is important, since movement blurs the images. PET and CT images are acquired in the same session. In some cases, CT contrast is given when it is clinically required. The scanner is open at both ends and does not touch the patient.
The team stays in contact throughout, usually through an intercom, and can be reached at any point.
Most patients resume routine activities unless they are told otherwise. Drinking fluids is usually advised, as this helps the body clear the remaining tracer. Some centers advise limiting close, prolonged contact with infants and pregnant women for a few hours as a precaution. The images are then reviewed and reported by a specialist, and the findings are discussed at the follow-up consultation.
Patients often ask about the scan time and are surprised that the appointment is longer than the imaging itself. It helps to think of the visit in four parts:
Total time varies by protocol, tracer, and individual clinical requirements, so centers generally give an expected duration at the time of booking rather than a fixed figure.
PET-CT is generally considered safe when clinically indicated and performed using appropriate protocols.
The examination does involve ionizing radiation from both the radiotracer and the CT component. The tracer dose is controlled and kept to the level needed for a diagnostic-quality image. Before a scan is recommended, the expected clinical benefit is weighed against that exposure.
A few situations need specific discussion:
Reactions to the radiotracer itself are uncommon. The injection feels much like a routine blood test, and the scan is not painful.
After the scan, patients may be given simple precautions to follow for a short period, such as drinking fluids and limiting extended close contact with young children.
A PET-CT report describes where tracer uptake is higher or lower than expected and what the CT images show at those locations.
Reports often mention SUV, or standardized uptake value. This is a number that expresses how much tracer has concentrated in a particular area relative to the rest of the body. It is one input among several. A higher SUV can indicate more active tissue, but it does not by itself confirm cancer, and values are not directly comparable across different scanners or protocols.
Comparison with previous imaging is often the most useful part of the interpretation, because a change over time can be more meaningful than a single measurement.
Scans are reviewed by a nuclear medicine specialist and read alongside the clinical history, examination findings, laboratory results and, where available, biopsy findings. At HCG, imaging is reviewed as part of the wider cancer-care pathway rather than in isolation.
Reporting time varies by center and by whether additional imaging or comparison studies are needed. Patients should ask the center when the report will be available and should discuss the findings with their treating specialist rather than interpreting numbers independently.
| Imaging test | Primarily shows | Common role |
|---|---|---|
| PET scan | Metabolic or functional activity | Shows areas with altered tracer uptake |
| CT scan | Anatomical structure | Shows the size and location of abnormalities |
| PET-CT | Metabolic activity plus structure | Combines PET findings with their anatomical location |
| MRI | Detailed soft-tissue anatomy | Useful for selected organs and clinical situations |
These tests are complementary rather than competing. No single modality is better than the others in every situation. The right choice depends on the cancer type, the organ being assessed, the clinical question being asked, and what previous imaging has already shown. Many patients undergo more than one type of scan over the course of their care.
Understanding both sides helps set realistic expectations before the scan and makes the follow-up discussion more useful.
PET-CT scan charges can vary depending on the radiotracer, scan protocol, use of contrast, clinical indication, and HCG center. Patients should contact their preferred center with the prescription to obtain a current estimate and confirm what is included.
PET-CT at HCG is delivered inside a dedicated cancer-care network, not as a stand-alone scanning service.
Nuclear medicine expertise. Scans are acquired and reported by nuclear medicine specialists working within HCG's oncology centers, not a general radiology pool.
PET-CT equipment. The network operates 21 PET-CT scanners, including an in-house cyclotron at HCG Cancer Hospital, K. R. Road, Bengaluru, supporting on-site production of certain radiotracers (figure from the PET-CT cost page confirm still current before publishing).
Oncology integration. Findings are read alongside the patient's existing diagnosis, prior imaging, and pathology rather than as an isolated test.
Multidisciplinary review. Complex or borderline findings can go to HCG's multidisciplinary tumor board for joint review by medical, surgical, and radiation oncology.
Report delivery. Reports are issued by the reporting center and shared with the treating specialist for discussion at the follow-up consultation.
Center-specific services. Scan types and radiotracers differ by location; check the confirmed technology at your preferred center above before booking.
Feel free to reach out to us.